Top Markets
#1 Status Status +19.55%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.58%
#3 GoPlus Security GoPlus Security +17.93%
#4 Wrapped NXM Wrapped NXM +14.89%
#5 Bedrock Bedrock +12.87%
#6 BankrCoin BankrCoin +12.81%
#7 Ontology Gas Ontology Gas +11.52%
#8 Pons Pons +9.76%
#9 DMT-NAT DMT-NAT +8.45%
#10 Janction Janction +7.35%
Coin of the day
Status Status
設定
言語
日本
通貨
USD
テーマ
HealthWarehouse.com, Inc. HealthWarehouse.com, Inc.

HealthWarehouse.com, Inc.

HEWA
株式のランク #34074
HealthWarehouse.com, Inc. functions as a digital and direct-mail pharmaceutical... HealthWarehouse.com, Inc. functions as a digital and direct-mail pharmaceutical service. Its offerings encompass a broad spectrum of pharmaceutical items, including generic and brand-name prescription drugs, specialized medications for pets, and a variety of over-the-counter remedies and goods. The company serves customers across all 50 U.S. states and the District of Columbia, specifically targeting the market for prescription drugs paid for directly by consumers. Sales are conducted directly to individual consumers via its online platform. Its corporate headquarters are situated in Florence, Kentucky.
株価
$0.11
最終同期: 2026-08-13
時価総額
$6.29M
変化（1日）
10.00%
変化（1年）
-33.13%
国
US
取引 HealthWarehouse.com, Inc. (HEWA)

カテゴリー

Healthcare
HealthWarehouse.com, Inc.（HEWA）の利益
2026 時点の利益 TTM: 0
HealthWarehouse.com, Inc. の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
HealthWarehouse.com, Inc. の利益の推移（2026 〜 2026）
各年末の利益
年 利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差 国
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US